US · Healthcare · Medical Care Facilities
EPS came in at 0.38 against a street estimate of 0.33 — a beat of 15.2%.
Analysts rate Acadia Healthcare Company Inc a buy (8 buy, 5 hold, 1 sell out of 14) with an average price target of $33.39.
| Fund | Stake |
|---|---|
| BlackRock Inc | 12.55% |
| Wellington Management Company LLP | 9.75% |
| FMR Inc | 7.38% |
| Khrom Capital Management, LLC | 5.58% |
| Vanguard Portfolio Management, LLC | 5.44% |
| Deerfield Management Co | 4.86% |
| Morgan Stanley - Brokerage Accounts | 4.82% |
| Abrams Bison Investments, LLC | 4.70% |
| Document | Date |
|---|---|
| Results announced · Q3 2026 | 2026-07-28 |
| Quarterly report · Q2 2026 | 2026-07-28 |
| Company announcement · Q2 2026 | 2026-05-18 |
| Shareholder vote results · Q2 2026 | 2026-05-06 |
| Quarterly report · Q1 2026 | 2026-04-30 |
| Results announced · Q2 2026 | 2026-04-29 |
| Proxy statement · Q2 2026 | 2026-03-25 |
| Annual report FY2025 | 2026-02-27 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Acadia Healthcare Company Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.